BRISTACYCLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bristacycline, and what generic alternatives are available?
Bristacycline is a drug marketed by Bristol and is included in two NDAs.
The generic ingredient in BRISTACYCLINE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bristacycline
A generic version of BRISTACYCLINE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BRISTACYCLINE?
- What are the global sales for BRISTACYCLINE?
- What is Average Wholesale Price for BRISTACYCLINE?
Summary for BRISTACYCLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Patent Applications: | 4,069 |
| DailyMed Link: | BRISTACYCLINE at DailyMed |
US Patents and Regulatory Information for BRISTACYCLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061658-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061888-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061888-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
